New revolutionary 3d Mammography has recently been approved by FDA . Houston Breast Imaging was one of the principle investigators of the recent trial on tomosynthesis. Dr. Rose has presented the data to the FDA panel, which helped gain the FDA approval.
Tomosynthesis is revolutionizing the way
we screen for breast cancer Read the article...
The webinar, ‘Digital Breast Tomosynthesis: An Intensive Case Review’, was presented to an international audience of over 500 physicians, nurses, and technologist... Learn more...
Podcast: Breast Tomosynthesis — One Practice's Experience Learn more...
New Tool to Catch Breast Cancer Early Now in Houston Learn more...
Revolutionary Mammography Reduces False Positives, Detects Small Tumors Learn more...
The Breast Cancer Risk Assessment Tool is an interactive tool designed by scientists at the National Cancer Institute (NCI) and the National Surgical Adjuvant Breast and Bowel Project (NSABP) to estimate a woman's risk of developing invasive breast cancer.
